Huons Global Co Ltd said its South Korean consortium plans to begin production of a single-dose Sputnik Light Covid-19 vaccine from as early as September.
The plan followed a request by the Russian Direct Investment Fund (RDIF), which markets the vaccine, and production would take place along with Sputnik V vaccines the consortium also intended to make for the sovereign wealth fund, Huons said.
The company said in April it would produce 100 million doses of Sputnik V Covid-19 vaccine a month for export, as Moscow sought to increase production globally to meet rising demand.
